In addition, in ccRCC patient–derived tumorgraft (PDX) cell lines that are VHL null, upon overexpression of VHL, we observed increased m6A modification (Supplemental Figure 2A). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.